[1]DITE P,BLAHO M,BOJKOVA M,et al.Nonalcoholic fatty pancreas disease:Clinical consequences[J].Dig Dis,2020,38(2):143-149.
[2]SILVA L,FERNANDES MSS,LIMA EA,et al.Fatty pancreas:Disease or finding[J].Clinics (Sao Paulo),2021,76:e2439.
[3]SEPE PS,OHRI A,SANAKA S,et al.A prospective evaluation of fatty pancreas by using EUS[J].Gastrointest Endosc,2011,73(5):987-993.
[4]SAQIB M,MARUF M,BASHIR S,et al.EUS-FNA,ancillary studies and their clinical utility in patients with mediastinal,pancreatic,and other abdominal lesions[J].Diagn Cytopathol,2020,48(11):1058-1066.
[5]朱欣,杨建辉,赵娟,等.胰腺钩突部肿瘤行超声内镜引导下针吸活检术的体会[J].中国内镜杂志,2021,27(04):81-85.
ZHU X,YANG JH,ZHAO J,et al.Experience of endoscopic ultrasonography-guided fine needle aspiration for pancreatic uncinate process tumor [J].China Journal of Endoscopy,2021,27(04):81-85.
[6]CAZACU IM,LUZURIAGA CHAVEZ AA,SAFTOIU A,et al.A quarter century of EUS-FNA:Progress,milestones,and future directions[J].Endosc Ultrasound,2018,7(3):141-160.
[7]KAWAMURA A,TAKAKURA K,TORISU Y,et al.Impact of qualitative endoscopic ultrasonography on fatty pancreas at a referral medical center[J].JGH Open,2022,6(1):44-49.
[8]MASAMUNE A,KIKUTA K,KUME K,et al.Nationwide epidemiological survey of chronic pancreatitis in Japan:introduction and validation of the new Japanese diagnostic criteria 2019[J].J Gastroenterol,2020,55(11):1062-1071.
[9]SHIMOSEGAWA T,KATAOKA K,KAMISAWA T,et al.The revised Japanese clinical diagnostic criteria for chronic pancreatitis[J].J Gastroenterol,2010,45(6):584-591.
[10]ILIC M,ILIC I.Epidemiology of pancreatic cancer[J].World J Gastroenterol,2016,22(44):9694-9705.
[11]MCGUIGAN A,KELLY P,TURKINGTON RC,et al.Pancreatic cancer:A review of clinical diagnosis,epidemiology,treatment and outcomes [J].World J Gastroenterol,2018,24(43):4846-4861.
[12]赵江桥,薛芝敏,杨佳平.胰腺癌相关危险因素的病例对照研究[J].现代肿瘤医学,2018,26(08):1229-1232.
ZHAO JQ,XUE ZM,YANG JP.A case-control study of the risk factors for pancreatic cancer[J].Modern Oncology,2018,26(08):1229-1232.
[13]HORI M,TAKAHASHI M,HIRAOKA N,et al.Association of pancreatic fatty infiltration with pancreatic ductal adenocarcinoma[J].Clin Transl Gastroenterol,2014,5(3):e53.
[14]KHOURY T,SBEIT W.Fatty pancreas and pancreatic cancer:An overlooked association[J].J Clin Med,2022,11(3):763-768.
[15]刘星,辰蒋慧,郑建明.胰腺脂肪浸润与胰腺癌关系的研究进展[J].中华胰腺病杂志,2020,20(06):473-476.
LIU X,CHEN JH,ZHENG JM.Research progress on the relationship between pancreatic fatty infiltration and pancreatic cancer [J].Chinese Journal of Pancreatology,2020,20(06):473-476.
[16]REBOURS V,GAUJOUX S,D'ASSIGNIES G,et al.Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanIN)[J].Clin Cancer Res,2015,21(15):3522-3528.
[17]GANDHI S,FUENTE J,MURAD MH,et al.Chronic pancreatitis is a risk factor for pancreatic cancer and incidence increases with duration of disease:A systematic review and meta-analysis [J].Clin Transl Gastroenterol,2022,13(3):e00463.
[18]KANDIKATTU HK,VENKATESHAIAH SU,MISHRA A.Chronic pancreatitis and the development of pancreatic cancer[J].Endocr Metab Immune Disord Drug Targets,2020,20(8):1182-1210.
[19]严欢,贾皑,张娟,等.超声内镜引导细针穿刺活检对胰腺占位性疾病的诊断价值[J].西安交通大学学报(医学版),2020,41(03):425-428.
YAN H,JIA A,ZHANG J,et al.The diagnosetic value of endoscopic ultrasonography-guiede fine needle asperation for pancreatic space-ocupying diseases[J].Journal of Xi'an Jiaotong University (Medical Sciences),2020,41(03):425-428.
[20]KITANO M,YOSHIDA T,ITONAGA M,et al.Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer[J].J Gastroenterol,2019,54(1):19-32.
[21]WANG KX,BEN QW,JIN ZD,et al.Assessment of morbidity and mortality associated with EUS-guided FNA:a systematic review[J].Gastrointest Endosc,2011,73(2):283-290.